Skip to main content
. 2023 Jun 7;18:1057–1066. doi: 10.2147/COPD.S404039

Table 3.

COPD Patients Who Received Triple Therapy Only

Crude Fully Adjusted Model Reduced (Stepwise)
Hazard Ratio 95% Confidence Interval P value Hazard Ratio 95% Confidence Interval P value Hazard Ratio 95% Confidence Interval P value
Lower Upper Lower Upper Lower Upper
History
Acute respiratory failure 1.883 1.654 2.143 <0.0001 1.48 1.294 1.693 <0.0001 1.48 1.294 1.691 <0.0001
Pneumonia 1.340 1.260 1.425 <0.0001 1.275 1.192 1.363 <0.0001 1.264 1.187 1.346 <0.0001
Comorbidities
Lung cancer 2.095 1.816 2.416 <0.0001 1.195 0.804 1.776 0.3788
Thoracic malignancies 2.077 1.816 2.374 <0.0001 1.586 1.091 2.306 0.0157 1.854 1.618 2.124 <0.0001
Bronchiectasis 1.102 0.974 1.246 0.1219 1.074 0.95 1.216 0.2546
Hypertensive diseases 1.205 1.139 1.275 <0.0001 1.093 1.029 1.16 0.0037 1.106 1.044 1.172 0.0006
Ischemic heart disease 1.161 1.088 1.239 <0.0001 1.031 0.952 1.117 0.4503
Heart failure 1.563 1.444 1.692 <0.0001 1.434 1.32 1.558 <0.0001 1.446 1.334 1.568 <0.0001
Stroke 1.296 1.161 1.447 <0.0001 1.165 1.041 1.303 0.0076 1.167 1.043 1.305 0.0069
Myocardial infarction 1.166 1.056 1.287 0.0024 0.999 0.888 1.125 0.9929
Cancer 1.636 1.477 1.813 <0.0001 1.436 1.294 1.595 <0.0001 1.437 1.295 1.596 <0.0001
Diabetes mellitus 1.190 1.103 1.283 <0.0001 1.059 0.979 1.145 0.1537
Renal diseases 1.939 1.707 2.203 <0.0001 1.605 1.408 1.828 <0.0001 1.611 1.415 1.835 <0.0001
Dementia/Alzheimer’s disease 1.799 1.474 2.195 <0.0001 1.487 1.216 1.819 0.0001 1.499 1.226 1.833 <0.0001